Therapeutic Asset Ratings

13,150 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Adrenomedullin Cerebral Arteriopathy, Autosomal Dominant, With Subcortical Infarcts And Leukoencephalopathy, Type 1	National Cerebral and Cardiovascular Center, Japan	P2	CCC (55)
Adriamycin Melanoma	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	P2	CCC (55)
Adriamycin Plasma Cell Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P2	CCC (55)
AIR Migraine Disorder	The University of Texas Health Science Center, Houston	P2	CCC (55)
Alemtuzumab Disease Related To Hematopoietic Stem Cell Transplant	University of Calgary	P2	CCC (55)
Alemtuzumab Aplastic Anemia	Masonic Cancer Center, University of Minnesota	P2	CCC (55)
Alemtuzumab Krabbe Disease	Masonic Cancer Center, University of Minnesota	P2	CCC (55)
Alemtuzumab Hemoglobinopathy	Masonic Cancer Center, University of Minnesota	P2	CCC (55)
Alemtuzumab Metachromatic Leukodystrophy	Masonic Cancer Center, University of Minnesota	P2	CCC (55)
Alirocumab Cerebral Atherosclerosis	Chang Gung Memorial Hospital	P2	CCC (55)
Allogeneic Msc Alzheimer Disease	Longeveron Inc.	P2	CCC (55)
Allopurinol Acute Myeloid Leukemia	OHSU Knight Cancer Institute	P2	CCC (55)
Alpelisib Ovarian Carcinoma	National Cancer Institute (NCI)	P2	CCC (55)
Alpha-Interferon Myelodysplastic Syndrome	Peking University People's Hospital	P2	CCC (55)
Alto-100 Major Depressive Disorder	Alto Neuroscience	P2	CCC (55)
Anastrozole Progesterone-Receptor Positive Breast Cancer	Ruth O'Regan	P2	CCC (55)
Anhydrous Enol-Oxaloacetate Breast Carcinoma In Situ	Jonsson Comprehensive Cancer Center	P2	CCC (55)
Anhydrous Enol-Oxaloacetate Breast Carcinoma	Jonsson Comprehensive Cancer Center	P2	CCC (55)
Anti-Cd7 Car-T Hematopoietic And Lymphoid System Neoplasm	Institute of Hematology & Blood Diseases Hospital, China	P2	CCC (55)
Anti-Human T-Lymphocyte Immunoglobulin, Rabbit Myelodysplastic Syndrome With Excess Blasts	M.D. Anderson Cancer Center	P2	CCC (55)
Aon-D21 Pneumonia	Aptarion Biotech AG	P2	CCC (55)
ap-101 Amyotrophic Lateral Sclerosis	Université de Sherbrooke	P2	CCC (55)
Apalutamide Hypogonadism	University of California, San Francisco	P2	CCC (55)
Astaxanthine Amyotrophic Lateral Sclerosis	Duke University	P2	CCC (55)
Atezolizumab Malignant Pleural Mesothelioma	Swiss Cancer Institute	P2	CCC (55)

Showing 2601 to 2625 of 13,150 assets

PreviousPage 105 of 526Next